Figure 2From: The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancerKaplan-Meier survival curves for progression-free survival. The progression-free survival rate was significantly worse in the low-AGR group than in the high-AGR group (p = 0.0171).Back to article page